

The Association of Racing Commissioners International released a report and accompanying press release Oct. 6, claiming that the Horseracing Integrity and Safety Authority's first year of operations had a questionable effect on equine breakdowns. The report also noted that after six months of HISA's Anti-Doping and Medication Control Program, no new drugs have been found.
At least several racing commissions have opposed HISA, either publicly or in court.
The release from ARCI is as follows:
A staff report from the Association of Racing Commissioners International was issued, providing data and a programmatic analysis of HISA programs after its first year responsible for equine and racetrack safety in Thoroughbred racing and six months of responsibility for its ADMC Program.
The main takeaways are:
The report was prepared for state racing commissions who anticipate being asked by state legislative oversight committees as to the performance of HISA in their state. It is considered preliminary and the first and only independent assessment of the new program. To date, there has been no congressional oversight or review by the Federal Trade Commission.
HISA issued a short response to the release and report from a spokesperson, stating: "HISA has just been made aware of the Association of Racing Commissioner International report released publicly today. The report is riddled with factual inaccuracies and mischaracterizations as evidenced by data and information that is publicly available on the HIWU website. HISA remains focused on enforcing and improving upon its Racetrack Safety and Anti-Doping and Medication Control Programs to advance safety and integrity in the sport."